腹部外科
腹部外科
복부외과
JOURNAL OF ABDOMINAL SURGERY
2014年
2期
133-136
,共4页
腹腔镜%胃切除术%胃肿瘤
腹腔鏡%胃切除術%胃腫瘤
복강경%위절제술%위종류
Laparoscopes%Gastrectomy%Stomach neoplasms
目的:探讨腹腔镜辅助胃癌根治术临床疗效。方法回顾性分析2010年1月至2013年7月间收治42例腹腔镜胃癌根治术患者的临床资料。结果42例均成功完成腹腔镜辅助胃癌根治术,其中全胃切除12例,近端胃切除6例,远端胃切除24例。32例行胃癌 D2根治术,6例行 D1+α(D1+第7组淋巴结)根治术,4例行 D1+β(D1+第7、8a、9组淋巴结)根治术。平均手术时间全胃切除为(310.0±35.5)min,近端胃切除为(260.5±28.5)min,远端胃切除为(200.4±40.2)min。平均术中出血量全胃切除为(270±60)ml,近端胃切除为(220±40)ml,远端胃切为(100±70)ml。术后并发症包括腹腔内出血1例,胃瘫2例,吻合口瘘1例,肺内感染1例。结论腹腔镜辅助下胃癌根治术是治疗进展期胃癌安全、可行且近期疗效良好的手术方法。
目的:探討腹腔鏡輔助胃癌根治術臨床療效。方法迴顧性分析2010年1月至2013年7月間收治42例腹腔鏡胃癌根治術患者的臨床資料。結果42例均成功完成腹腔鏡輔助胃癌根治術,其中全胃切除12例,近耑胃切除6例,遠耑胃切除24例。32例行胃癌 D2根治術,6例行 D1+α(D1+第7組淋巴結)根治術,4例行 D1+β(D1+第7、8a、9組淋巴結)根治術。平均手術時間全胃切除為(310.0±35.5)min,近耑胃切除為(260.5±28.5)min,遠耑胃切除為(200.4±40.2)min。平均術中齣血量全胃切除為(270±60)ml,近耑胃切除為(220±40)ml,遠耑胃切為(100±70)ml。術後併髮癥包括腹腔內齣血1例,胃癱2例,吻閤口瘺1例,肺內感染1例。結論腹腔鏡輔助下胃癌根治術是治療進展期胃癌安全、可行且近期療效良好的手術方法。
목적:탐토복강경보조위암근치술림상료효。방법회고성분석2010년1월지2013년7월간수치42례복강경위암근치술환자적림상자료。결과42례균성공완성복강경보조위암근치술,기중전위절제12례,근단위절제6례,원단위절제24례。32례행위암 D2근치술,6례행 D1+α(D1+제7조림파결)근치술,4례행 D1+β(D1+제7、8a、9조림파결)근치술。평균수술시간전위절제위(310.0±35.5)min,근단위절제위(260.5±28.5)min,원단위절제위(200.4±40.2)min。평균술중출혈량전위절제위(270±60)ml,근단위절제위(220±40)ml,원단위절위(100±70)ml。술후병발증포괄복강내출혈1례,위탄2례,문합구루1례,폐내감염1례。결론복강경보조하위암근치술시치료진전기위암안전、가행차근기료효량호적수술방법。
Objective To explore the efficacies of laparoscopy- assisted gastrectomy (LAG)for gastric cancer.Methods The data of 42 patients undergoing LAG between January 2010 and July 2013 were collected retrospectively.Results All of them underwent LAG.Total (n =12),proximal (n =6) and distal (n =24)gastrectomies were performed.And the lymph node dissections included D1 +α(D1 +no.7)(n =6),D1 +β(D1 +no.7,8a & 9)(n =4)and D2 (n =32).For total,proximal and distal gastrectomies,the average operative duration was (3 10.0±35.5),(260.5 ±28.5)and (200.4 ±40.2)min and the average blood loss volume (270±60),(260.5±28.5)and (100±70)ml respec-tively.The postoperative outcomes were intra-abdominal hemorrhage (n = 1 ),gastrasthenia (n =2),anastomotic leakage (n =1)and lung infection (n =1).Conclusions LAG is both safe and feasible for advanced gastric cancer with mini-invasion and quick postoperative recovery.